MSLE
Satellos Bioscience, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CA
$6.44
−0.31%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.60
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.56
- EPS estimate
- -$0.51
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -13.8%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $21
- PT range
- $18 – $24
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.51 | -$0.56 | Miss -9.73% | — |
| May 14, 2026 | -$0.51 | -$0.53 | Miss -3.92% | — |
| Mar 27, 2026 | -$0.36 | -$0.47 | Miss -30.56% | — |
| Nov 14, 2025 | -$0.33 | -$0.36 | Miss -11.14% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026